WesBanco Bank’s Abivax ABVX Stock Holding History

WesBanco Bank’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$557K	Hold	5,000	–	–	0.02%	469
2025 Q4	$674K	Buy	+5,000	New	+$546K	0.02%	426

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

WesBanco Bank's ABVX Position: Q1 2026 in Review

WesBanco Bank held its Abivax (ABVX) position steady in Q1 2026 at 5,000 shares worth $557K. The position accounts for 0.02% of the portfolio, ranked #469.

WesBanco Bank first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $674K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

WesBanco Bank held 5,000 shares of Abivax worth $557K as of Q1 2026.
WesBanco Bank left its Abivax share count unchanged in Q1 2026.
Abivax made up 0.02% of WesBanco Bank's portfolio in Q1 2026, its #469 holding.
WesBanco Bank first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
WesBanco Bank's Abivax position peaked at $674K in Q4 2025.
254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on WesBanco Bank's 13F filing for Q1 2026, filed 21 Apr 2026.